Literature DB >> 612069

[Vigilance: psychophysiologic aspects].

D Bente.   

Abstract

Mesh：

Year:  1977        PMID： 612069

Source DB:  PubMed          Journal:  Verh Dtsch Ges Inn Med        ISSN： 0070-4067


× No keyword cloud information.
  10 in total

1.  Electroencephalographic vigilance dynamics in multiple sclerosis during an acute episode and after remission.

Authors:  H Bräu; G Ulrich
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

2.  EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.

Authors:  M Saletu; P Anderer; G M Saletu-Zyhlarz; M Mandl; O Arnold; J Zeitlhofer; B Saletu
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

3.  EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug.

Authors:  B Saletu; A Darragh; P Salmon; R Coen
Journal:  Br J Clin Pharmacol       Date:  1989-07       Impact factor: 4.335

4.  A modern neurobiological concept of vigilance.

Authors:  W P Koella
Journal:  Experientia       Date:  1982-12-15

5.  Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA).

Authors:  B Saletu; P Anderer; G M Saletu-Zyhlarz; D Gruber; M Metka; J Huber
Journal:  Psychopharmacology (Berl)       Date:  2004-11-03       Impact factor: 4.530

6.  EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease.

Authors:  Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda M Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
Journal:  J Neurol       Date:  2010-12-12       Impact factor: 4.849

7.  Comparative EEG mapping studies in Huntington's disease patients and controls.

Authors:  Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda M Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
Journal:  J Neural Transm (Vienna)       Date:  2010-10-08       Impact factor: 3.575

8.  EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.

Authors:  Michael T Saletu; Peter Anderer; Gerda M Saletu-Zyhlarz; Magdalena Mandl; Oliver Arnold; Dorothea Nosiska; Josef Zeitlhofer; Bernd Saletu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

9.  Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry.

Authors:  B Saletu; J Grünberger; L Linzmayer; P Anderer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.

Authors:  Michael Kluge; Ulrich Hegerl; Christian Sander; Jens Dietzel; Roland Mergl; Istvan Bitter; Koen Demyttenaere; Ricardo Gusmão; Ana Gonzalez-Pinto; Victor Perez-Sola; Eduard Vieta; Georg Juckel; Ulrich S Zimmermann; Michael Bauer; Pascal Sienaert; Sónia Quintão; Marc-Andreas Edel; Csilla Bolyos; Jose Luis Ayuso-Mateos; Pilar López-García
Journal:  BMC Psychiatry       Date:  2013-02-27       Impact factor: 3.630
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.